These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32202925)
1. The Hong T; Luo M; Liu Q Genet Test Mol Biomarkers; 2020 Apr; 24(4):181-187. PubMed ID: 32202925 [No Abstract] [Full Text] [Related]
2. TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations. Dahlström J; Liu T; Yuan X; Saft L; Ghaderi M; Wei YB; Lavebratt C; Li P; Zheng C; Björkholm M; Xu D Ann Hematol; 2016 Oct; 95(11):1825-32. PubMed ID: 27561898 [TBL] [Abstract][Full Text] [Related]
3. Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100. Krahling T; Balassa K; Kiss KP; Bors A; Batai A; Halm G; Egyed M; Fekete S; Remenyi P; Masszi T; Tordai A; Andrikovics H Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):98-104. PubMed ID: 26487696 [TBL] [Abstract][Full Text] [Related]
4. The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis. Li H; Xu Y; Mei H; Peng L; Li X; Tang J Oncotarget; 2017 Jun; 8(24):38693-38705. PubMed ID: 28418878 [TBL] [Abstract][Full Text] [Related]
5. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients. Trifa AP; Bănescu C; Tevet M; Bojan A; Dima D; Urian L; Török-Vistai T; Popov VM; Zdrenghea M; Petrov L; Vasilache A; Murat M; Georgescu D; Popescu M; Pătrinoiu O; Balea M; Costache R; Coleș E; Șaguna C; Berbec N; Vlădăreanu AM; Mihăilă RG; Bumbea H; Cucuianu A; Popp RA Br J Haematol; 2016 Jul; 174(2):218-26. PubMed ID: 27061303 [TBL] [Abstract][Full Text] [Related]
6. The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies. Zou P; Gu A; Ji G; Zhao L; Zhao P; Lu A BMC Cancer; 2012 Jan; 12():7. PubMed ID: 22221621 [TBL] [Abstract][Full Text] [Related]
7. TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients. Matsuguma M; Yujiri T; Yamamoto K; Kajimura Y; Tokunaga Y; Tanaka M; Tanaka Y; Nakamura Y; Tanizawa Y Int J Hematol; 2019 Dec; 110(6):690-698. PubMed ID: 31571131 [TBL] [Abstract][Full Text] [Related]
8. Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms. Jäger R; Harutyunyan AS; Rumi E; Pietra D; Berg T; Olcaydu D; Houlston RS; Cazzola M; Kralovics R Am J Hematol; 2014 Dec; 89(12):1107-10. PubMed ID: 25196853 [TBL] [Abstract][Full Text] [Related]
9. Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population. Xing YL; Liu F; Li JF; Lin JC; Zhu GD; Li M; Zhang CR; Niu YY J Clin Lab Anal; 2016 Nov; 30(6):1071-1077. PubMed ID: 27154632 [TBL] [Abstract][Full Text] [Related]
10. Association between the rs2736100 polymorphisms of telomerase reverse transcriptase gene and digestive cancers: A meta-analysis. Song H; Han M; Li K; Zhao Y; Xu C; Lei X J Cancer Res Ther; 2021 Nov; 17(5):1202-1208. PubMed ID: 34850768 [TBL] [Abstract][Full Text] [Related]
11. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma. Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744 [TBL] [Abstract][Full Text] [Related]
12. The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma. Yuan X; Cheng G; Yu J; Zheng S; Sun C; Sun Q; Li K; Lin Z; Liu T; Li P; Xu Y; Kong F; Bjorkholm M; Xu D Oncotarget; 2017 Apr; 8(14):23120-23129. PubMed ID: 28416747 [TBL] [Abstract][Full Text] [Related]
13. Ethnicity-specific association between TERT rs2736100 (A > C) polymorphism and lung cancer risk: a comprehensive meta-analysis. Wu X; Huang G; Li W; Chen Y Sci Rep; 2023 Aug; 13(1):13271. PubMed ID: 37582820 [TBL] [Abstract][Full Text] [Related]
14. The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population. Yuan X; Meng Y; Li P; Ge N; Kong F; Yang L; Björkholm M; Zhao S; Xu D Oncotarget; 2016 May; 7(22):31972-9. PubMed ID: 26934125 [TBL] [Abstract][Full Text] [Related]
15. TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis. Zhang X; Chen Y; Yan D; Han J; Zhu L Biochem Genet; 2022 Feb; 60(1):241-266. PubMed ID: 34181135 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene, gene- gene and gene-smoking interaction with susceptibility to gastric cancer in Chinese Han population. Zhang J; Ju H; Gao JR; Jiao XL; Lu Y Oncotarget; 2017 Mar; 8(12):20235-20243. PubMed ID: 28423629 [TBL] [Abstract][Full Text] [Related]
17. [The relationship between gene polymorphism of telomerase reverse transcriptase and susceptibility to hepatocellular carcinoma]. Ding CY; Hu LM; Hu ZB; Shen HB Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):593-6. PubMed ID: 22041560 [TBL] [Abstract][Full Text] [Related]
18. TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects. Wang HM; Zhang XY; Jin B Genet Test Mol Biomarkers; 2013 Dec; 17(12):937-41. PubMed ID: 24283584 [TBL] [Abstract][Full Text] [Related]
19. Association between telomerase reverse transcriptase rs2736100 polymorphism and risk of glioma. Zhou P; Wei L; Xia X; Shao N; Qian X; Yang Y J Surg Res; 2014 Sep; 191(1):156-60. PubMed ID: 24888789 [TBL] [Abstract][Full Text] [Related]
20. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. Mocellin S; Verdi D; Pooley KA; Landi MT; Egan KM; Baird DM; Prescott J; De Vivo I; Nitti D J Natl Cancer Inst; 2012 Jun; 104(11):840-54. PubMed ID: 22523397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]